pathwire
 
 
 
 
Hot off the Press! Former FDA Investigator to Present at PathWise CAPA Workshop-__________________________________________________
 
PathWise is pleased to welcome former FDA Investigator and content expert, Dannie Rowland, to their upcoming CAPA Workshop to be held in Newport Beach, California.  
 
Rowland will host a general session covering topics such as common regulatory struggles faced by manufacturers and best practices for Quality System improvements.
 
Read the press release.
Complimentary Article Download: International Labeling Challenges of Medical Device Manufacturers
__________________________________________________ 
 
Medical device manufacturers face an array of challenges in delivering products to international markets. Complying with diverse and evolving regulatory requirements that vary by country, providing country-specific translations, and ensuring compliance and consistency throughout the global supply chain are critical to successful labeling, documentation, and packaging processes.
 
This article will address the challenges in delivering product to global markets, and provide best practices for success.

Download the article.
Design Thinking vs. Six Sigma: Welcoming the New, Improving the Old
__________________________________________________ 
 
For decades, companies from Cisco Systems to Staples to Bank of America have worked to embed the basic techniques of Six Sigma, the business approach that relies on measurement and analysis to make operations as efficient as possible.

More recently, in the last 5 to 10 years, they have been told they must master a new set of skills known as "design thinking." Aiming to help companies innovate, design thinking starts with an intense focus on understanding real problems customers face in their day-to-day lives. 
 
Read the full article.
Community Poll: What is the biggest challenge in locating the root cause of a CAPA?
__________________________________________________
 
Getting burned by fire fighting? Too often expensive problems are never resolved and reoccur because of the difficulty in locating the root cause.  
 
What is your biggest challenge in locating the root cause of a CAPA?

Vote now.
New Warning Letter "Closeout" Program from the FDA
__________________________________________________
 
Beginning this month, the FDA may now issue a Warning Letter close-out letter once the Agency has completed an evaluation of corrective actions undertaken by a firm in response to a Warning Letter. 
 
A close-out letter may issue when, based on FDA's evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009. 
  
Read the program announcement.
Join PathWise on Facebook
__________________________________________________ 
 
Come visit our new fan page on Facebook, where you'll find the latest news & events that PathWise has to offer.
 
Visit our fan page.

Monthly Newsletter 

PathWise, Inc. 

September 2009 

 image
 
 
 
Best Practices
to Manage an FDA Inspection
 
When it comes to quality system audits, the level of preparation within your organization can make a significant difference in your level of success. This webinar discusses how to effectively prepare for and manage an FDA inspection.

For more information or to purchase.

_________________
 
Integrating ISO 14971 and ICH Q9 into the Quality System
 
This webinar provides insight into the necessary industry standards and offers meaningful techniques that risk management professionals can use to implement ISO 14971 and ICH Q9 into their quality system.

For more information or to purchase.
 
_________________
 

Integrating FDA and Trending Requirements into your CAPA System
 
This session offers attendees a "how-to" approach to effectively integrate the FDA's CAPA and Trending requirements, providing them with the skills necessary to develop a strong, sustainable and compliant CAPA system.

For more information or to purchase.

_________________
 
 
Conducting OOS and Non-Conformance Investigations
 
This webinar provides a process to effectively expedite and document OOS and non-conformance investigations to increase compliance in your organization. 

 
PathWise is pleased to announce the availability of our latest CFR, ICH and QSIT resource guides. These handy pocket-size booklets are an ideal way to keep your organization informed of the most current FDA regulations and guidelines.
 
Available guides include:
  • 21 CFR 820  - Quality System Regulations
  • 21 CFR 210-211 - Pharmaceutical GMPs
  • 21 CFR 111 - Dietary Supplements
  • 21 CFR 606 - Blood Industry
  • ICH Q9 - Risk Management for Pharmaceuticals
  • ICH Q10 - Quality Systems for Pharmaceuticals
  • QSIT for Medical Devices

Order Online

________________________________________________________________________________

                                                                  Facing an uphill battle?   

PathWise is a training and consulting firm that works with medical device, pharmaceutical and biotechnology companies in the areas of quality and compliance. We deliver the methodology and tools to ensure compliant, effective and efficient execution of quality system requirements. 
  
Root Cause Analysis                       Risk Management                              Documentation

                      CAPA                                              Quality Systems Regulation               Auditing 
 
_______________________________________________________________________________________________________ 
 

          

                  Please visit us online at www.PathWise.com or call 866.580.PATH for more information